EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Corporate Developments

NEXT STORY
Apollomics, Inc. Announces Successful Enrollment of First Patient Into Phase 1 Clinical Trial of APL-106 (Uproleselan Injection) in China
PREV STORY
Sotherly Hotels Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

FDA grants Breakthrough Device Designation for Roche’s Elecsys GALAD score to support earlier diagnosis of hepatocellular carcinoma

author_avatar
NASDAQ Market News

Notification from Oasmia Pharmaceutical

Oasmia Pharmaceutical AB (publ) hereby notify that the Company, Arwidsro Investment and MGC Capital ...

author_avatar
NASDAQ Market News

ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences

author_avatar
NASDAQ Market News